In contrast, the non-PCOS group with hyperprolactinemia revealed both a decrease in the homeostatic model assessment of insulin resistance and PRL, suggesting that testosterone impaired the PRL decrease [12]. The gene discussed is PRL; the disease is polycystic ovary syndrome.